Logar, C M <br/><br/>
Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo.  [electronic resource] 

 -  Kidney international  Aug 2007 
 - 489-98 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0085-2538 
<br/><br/><label>Standard No.: </label>10.1038/sj.ki.5002362  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies<br/>Apoptosis--drug effects<br/>Autoantibodies<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Darbepoetin alfa<br/>Disease Models, Animal<br/>Disease Progression<br/>Erythropoietin--analogs & derivatives<br/>Glomerulonephritis--complications<br/>Glomerulosclerosis, Focal Segmental--etiology<br/>Janus Kinase 2--metabolism<br/>Mice<br/>Podocytes--drug effects<br/>Protective Agents--pharmacology<br/>Proteinuria--etiology<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Puromycin Aminonucleoside--pharmacology<br/>Receptors, Erythropoietin--drug effects<br/>Signal Transduction--drug effects<br/>Transforming Growth Factor beta1--metabolism<br/>Ultraviolet Rays